The latest quarterly R&D expense is $334.00 Million with a QoQ Growth of +9.87%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $334.00M.
$334.00M
$334.00 Million
Q2 FY2026 · 2026-06-30
+9.87%
vs. $304.00M prior quarter
14
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $334.00M | +9.87% | +18.44% |
| Q1 FY2026Period end 2026-03-31 | $304.00M | -16.94% | +27.20% |
| Q4 FY2025Period end 2025-12-31 | $366.00M | +18.06% | +38.11% |
| Q3 FY2025Period end 2025-09-30 | $310.00M | +9.93% | +27.57% |
| Q2 FY2025Period end 2025-06-30 | $282.00M | +17.99% | +18.99% |
| Q1 FY2025Period end 2025-03-31 | $239.00M | -9.81% | +0.84% |
| Q4 FY2024Period end 2024-12-31 | $265.00M | +9.05% | +3.92% |
| Q3 FY2024Period end 2024-09-30 | $243.00M | +2.53% | +8.97% |
| Q2 FY2024Period end 2024-06-30 | $237.00M | 0.00% | +9.72% |
| Q1 FY2024Period end 2024-03-31 | $237.00M | -7.06% | +17.33% |
| Q4 FY2023Period end 2023-12-31 | $255.00M | +14.35% | N/A |
| Q3 FY2023Period end 2023-09-30 | $223.00M | +3.24% | N/A |
| Q2 FY2023Period end 2023-06-30 | $216.00M | +6.93% | N/A |
| Q1 FY2023Period end 2023-03-31 | $202.00M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
